RiverPark Advisors’s Strata Critical Medical Inc SRTA Stock Holding History
Bought
Maintained
Sold
Other funds holding SRTA
AIM
HVCM
NAMA
EMG
AIM
RiverPark Advisors's SRTA Position: Q4 2021 in Review
RiverPark Advisors sold out of Strata Critical Medical Inc (SRTA) in Q4 2021, closing a stake of 600,780 shares — an estimated $6.25M sold.
RiverPark Advisors first reported a position in SRTA in Q4 2020 and held it in 3 quarters. The position peaked at $6.31M in Q2 2021. 79 funds tracked by Wall St. Rank hold SRTA as of Q4 2021.
- RiverPark Advisors reported no remaining Strata Critical Medical Inc position as of Q4 2021 after selling out during the quarter.
- RiverPark Advisors sold 600,780 Strata Critical Medical Inc shares in Q4 2021, an estimated $6.25M.
- RiverPark Advisors first reported a position in Strata Critical Medical Inc in Q4 2020 and held it in 3 quarters.
- RiverPark Advisors's Strata Critical Medical Inc position peaked at $6.31M in Q2 2021.
- 79 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q4 2021.
Based on RiverPark Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.